BME logo

Blackrock Health Sciences Trust (BME)

$47.08

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BME

AUM

$627718487

P/E ratio

--

Dividend yield

6.489%

Expense ratio

1.14%

Beta

0.605393

Price on BME

Previous close

$47.59

Today's open

$47.69

Day's range

$47 - $48.15

52 week range

$37.51 - $48.30

Profile about BME

Headquarters

US

Exchange

New York Stock Exchange

Issue type

Common Stock

BME industries and sectors

Industries

Health

News on BME

Weekly Closed-End Fund Roundup (November 8, 2026)

CEFs were mixed this week: 14 of 26 sectors rose on price (average -0.17%), led by Commodities (+5.05%), while MLPs fell the most (-12.19%). On NAV, 15 of 26 sectors rose (average -0.35%). The average sector discount was -8.70%, with Senior Loans the widest at -20.87%. OXLC halved its monthly distribution to $0.10 from January and fell -23.33%; our OXLC/CCIF rotation turned 1,200 OXLC shares into 1,670 in five weeks, about 40% in free shares.

news source

Seeking Alpha • 12 hours ago

news preview

Weekly Closed-End Fund Roundup (November 1, 2026)

CEFs gained on price this week: 21 of 26 sectors rose (average +1.13%), led by MLPs (+5.68%), while Commodities fell the most (-5.45%). NAVs lagged prices: 20 of 26 sectors rose on NAV (average +0.23%), and the average premium/discount change was +0.82%, led by California Munis (+2.21%). SABA paid a $0.155 special dividend from income carried over from its previous fiscal year; its regular $0.058 monthly distribution is unchanged.

news source

Seeking Alpha • Nov 10, 2026

news preview

Weekly Closed-End Fund Roundup (October 25, 2026)

CEFs fell this week: 4 of 26 sectors rose on price (average -0.90%) and 8 of 26 on NAV (average -0.20%); munis held up while commodities lagged. HERZ's tender for 5% of its shares at 97.5% of NAV drew 71% participation, so only about 7% of tendered shares were accepted, worth about +1.4% on a full position. At the fund level, HQH (+6.80%) led on price and OCCI (-17.42%) fell the most, while THW (+5.18%) led on NAV and ASA (-5.78%) declined the most.

news source

Seeking Alpha • Nov 2, 2026

news preview

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

news source

Business Wire • Oct 30, 2026

news preview

BME: It Keeps Paying, I Keep Holding

BlackRock Health Sciences Trust remains a solid, long-term, defensive healthcare closed-end fund, but it's still trading at a narrow discount. BME offers a steady monthly distribution yield, though the fund is relying primarily on capital gains rather than underlying dividends for coverage. Eli Lilly is BME's largest holding, benefiting from robust growth expectations and contributing significantly to portfolio appreciation.

news source

Seeking Alpha • Oct 28, 2026

news preview

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

BlackRock Health Sciences Trust remains a steady income generator, never having cut its regular distribution since inception, despite recent lackluster results. BME's discount has narrowed, resulting in some outperformance relative to XLV on total share price return. I continue to hold BME for long-term income, viewing the current healthcare sector undervaluation as a potential opportunity for cautious, incremental additions.

news source

Seeking Alpha • May 22, 2026

news preview

BME: Removal Of Option Writing Can Improve NAV Growth (Rating Upgrade)

BlackRock Health Sciences Trust is upgraded to a buy, benefiting from its shift to an equity-focused strategy and improved NAV growth prospects. BME offers an 8.3% monthly dividend yield, but coverage is inconsistent and reliant on net realized gains rather than stable investment income. Elimination of the option writing strategy positions BME to better capture upside in healthcare, especially with exposure to GLP-1 drug market leaders.

news source

Seeking Alpha • Mar 29, 2026

news preview

5 ‘Healthy' Dividends Paying Up To 14.1%

Healthcare dividend stocks are selling off with the turbulence in the Middle East.

news source

Forbes • Mar 22, 2026

news preview

7 Income-Oriented CEFs With Rising NAV And Distribution Increases For At Least 10+ Years

I highlight seven closed-end funds, or CEFs, with rising NAVs and increasing distributions over the past 10–15 years, spanning diverse asset classes. These CEFs—PEO, BDJ, BME, CSQ, UTF, STK, and GDV—offer strong total returns, resilient income growth, and trade at attractive discounts to NAV. Funds like STK and CSQ have outperformed the S&P 500 on a 10-year total return basis, while others like BME and UTF have never cut distributions.

news source

Seeking Alpha • Mar 22, 2026

news preview

Never Cutters, Part 2: 5 More High-Yield CEFs That Have Never Cut The Distribution

I highlight five additional CEFs—BIT, BME, BST, BUI, and GLU—that have never cut distributions for at least a decade, offering high-yield, monthly income. BIT yields nearly 12% at a -6.8% discount, but declining earnings coverage and rising ROC signal caution on distribution sustainability. BME, BST, and BUI trade at discounts and have recently increased distributions, with BST delivering an 18% 10-year total return at market price.

news source

Seeking Alpha • Mar 15, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Blackrock Health Sciences Trust

Open an M1 investment account to buy and sell Blackrock Health Sciences Trust commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BME on M1